About: Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Mutations in the substrate of the HIV-1 protease, especially changes in the NC/p1 cleavage site, can act not only as compensatory mutations but can also directly contribute to protease inhibitor (PI) resistance. These NC/p1 changes bring about PI resistance by causing an enhanced processing of the Gag protein. To investigate the capacity of HIV to modulate Gag cleavage and its consequences for protease inhibitor resistance and replicative capacity (RC), we performed a detailed enzymatic and virological analysis using a set of PI resistant NC/p1 variants (HXB2436E+437T, HXB2437T, HXB2437V and HXB2431V). Here we demonstrate that single NC/p1 mutants, which displayed only a slight increase in PI resistance didn’t show an obvious change in RC. In contrast, the double NC/p1 mutant, which displayed a clear increase in processing efficiency and PI resistance, also demonstrated a clear reduction in RC. Evolution experiments revealed that this decrease in RC could be (partially) restored by either reversion of the 436E change or by the acquisition of additional changes at codon 435 or 438. Furthermore, these changes also normalized Gag processing efficiency and returned PI susceptibility in the direction of wild type level. The results of this study demonstrate that when enhanced Gag processing due to PI resistance mutations in NC/p1 reduces RC, HIV-1 can modulate the NC/p1 sequence to restore RC and Gag cleavage to an optimal rate.
  • Mutations in the substrate of the HIV-1 protease, especially changes in the NC/p1 cleavage site, can act not only as compensatory mutations but can also directly contribute to protease inhibitor (PI) resistance. These NC/p1 changes bring about PI resistance by causing an enhanced processing of the Gag protein. To investigate the capacity of HIV to modulate Gag cleavage and its consequences for protease inhibitor resistance and replicative capacity (RC), we performed a detailed enzymatic and virological analysis using a set of PI resistant NC/p1 variants (HXB2436E+437T, HXB2437T, HXB2437V and HXB2431V). Here we demonstrate that single NC/p1 mutants, which displayed only a slight increase in PI resistance didn’t show an obvious change in RC. In contrast, the double NC/p1 mutant, which displayed a clear increase in processing efficiency and PI resistance, also demonstrated a clear reduction in RC. Evolution experiments revealed that this decrease in RC could be (partially) restored by either reversion of the 436E change or by the acquisition of additional changes at codon 435 or 438. Furthermore, these changes also normalized Gag processing efficiency and returned PI susceptibility in the direction of wild type level. The results of this study demonstrate that when enhanced Gag processing due to PI resistance mutations in NC/p1 reduces RC, HIV-1 can modulate the NC/p1 sequence to restore RC and Gag cleavage to an optimal rate. (en)
Title
  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity (en)
skos:prefLabel
  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity
  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity (en)
skos:notation
  • RIV/61388963:_____/12:00377476!RIV13-AV0-61388963
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(AV0Z40550506)
http://linked.open...iv/cisloPeriodika
  • 29
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 151481
http://linked.open...ai/riv/idVysledku
  • RIV/61388963:_____/12:00377476
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • HIV-1; protease; Gag; resistance; cleavage (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [36DAA30474D3]
http://linked.open...i/riv/nazevZdroje
  • Retrovirology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 9
http://linked.open...iv/tvurceVysledku
  • Lepšík, Martin
  • Fun, A.
  • Maarseveen van, N. M.
  • Nijhuis, M.
  • Schipper, P. J.
  • Andersson, Dan
  • Boucher, Ch. A. B.
  • Jong de, D.
http://linked.open...ain/vavai/riv/wos
  • 000303870000001
http://linked.open...n/vavai/riv/zamer
issn
  • 1742-4690
number of pages
http://bibframe.org/vocab/doi
  • 10.1186/1742-4690-9-29
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 48 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software